Clinical and Biological Characteristics of Hidradenitis Suppurativa
University of California, San Francisco · NCT03967600
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 13+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1000
- US sites recruiting
- 1
- Study start
- July 15, 2016
- Record last updated
- May 4, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
Conditions: Hidradenitis Suppurativa
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Hidradenitis Suppurativa Patients
Inclusion Criteria
- Age 13 years or older
- Diagnosis of HS clinically-confirmed by a physician
Exclusion Criteria
- Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.
Healthy Volunteer
Inclusion Criteria
- No history of chronic skin conditions
- No recent history of antibiotic use
Exclusion Criteria
- Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.
Recruiting US locations
University of California, San Francisco
San Francisco, CA 94115
Site contact: Maia Paul, MPH · 415-502-4741 · Maia.Paul@ucsf.edu
Study contacts (from the official record)
- Kaelin Chatterley · 415-961-3786 · Kaelin.Chatterley@ucsf.edu
Similar studies in California
All dermatology studies in California →- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- West Hills, CA + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Bambusa Therapeutics
- Location
- Irvine, CA + 2 other US sites
- Eligibility basics
- Ages 18–72
- RecruitingHealthy volunteersPhase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Pfizer
- Location
- Anaheim, CA + 4 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
Sitryx Therapeutics Ltd
- Location
- Fremont, CA + 5 other US sites
- Eligibility basics
- Ages 18–65